We are excited to be participating in Canaccord Genuity’s 44th Annual Growth Conference, hosted in Boston! Tomorrow, August 14th, our CEO, Paulash Mohsen, will be presenting at 11:30 AM EST.
Vesigen Therapeutics, Inc.
Biotechnology Research
Cambridge, Massachusetts 4,625 followers
Delivering intracellular therapeutics with ARMMed microvesicles
About us
Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables us to deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets. Our team is committed to leveraging ARMMs technology to enable new therapies and address currently unmet medical needs.
- Website
-
https://www.vesigen.com/
External link for Vesigen Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
Locations
-
Primary
790 Memorial Dr
Suite 103
Cambridge, Massachusetts 02139, US
Employees at Vesigen Therapeutics, Inc.
Updates
-
Vesigen Therapeutics, Inc. reposted this
Paulash Mohsen, CEO of Vesigen Therapeutics, Inc., discusses the company’s delivery technology, its advantages over viral vectors and liquid nanoparticles, and how they enable the targeting of previously undruggable targets. https://lnkd.in/gHWrUraF
-
Vesigen Therapeutics, Inc. reposted this
Just one more day until Joe Nabhan will be speaking about our engineered #ARMMs platform at the Next Generation Gene Therapy Vectors Summit!
Our CSO, Joe Nabhan, will be speaking at the 4th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston) about recent advances made to our engineered #ARMMs platform.
-
Vesigen Therapeutics, Inc. reposted this
Did you know every 2 seconds someone in the US needs blood and/or platelets? 1 blood donation can save up to 3 lives! That's why we are hosting a mobile blood drive at our office on Tuesday July 16th from 9:00-2:30. There are plenty of spots available and it's open to the public. Our office is located at 790 Memorial Drive in Cambridge, MA. Help us give back to the community by signing up here: https://lnkd.in/eHzpK7nm
-
Did you know every 2 seconds someone in the US needs blood and/or platelets? 1 blood donation can save up to 3 lives! That's why we are hosting a mobile blood drive at our office on Tuesday July 16th from 9:00-2:30. There are plenty of spots available and it's open to the public. Our office is located at 790 Memorial Drive in Cambridge, MA. Help us give back to the community by signing up here: https://lnkd.in/eHzpK7nm
Mass General - Donor Portal
blooddonor.massgeneral.org
-
Just one more day until Joe Nabhan will be speaking about our engineered #ARMMs platform at the Next Generation Gene Therapy Vectors Summit!
Our CSO, Joe Nabhan, will be speaking at the 4th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston) about recent advances made to our engineered #ARMMs platform.
-
Our CSO, Joe Nabhan, will be speaking at the 4th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston) about recent advances made to our engineered #ARMMs platform.
-
Vesigen Therapeutics, Inc. reposted this
I am excited to attend BIO International Convention next week from June 3-6 in San Diego, CA. Send me an invite in the partnering portal if you'd like to learn about Vesigen Therapeutics, Inc. non-viral delivery technology. #BIO2024 #nonviral #delivery #geneediting
-
That's a wrap on our time at #ARVO2024 and #ASGCT2024! Check out our press release at the link below for a recap of what was presented last week. https://lnkd.in/eb83Zxk7
-
Join us for our final presentations of #ASGCT2024 at 12:00 PM today!